Bone Marrow Transplant: A Complete Patient Guide

A bone marrow transplant is one of the more intensive treatments in hematology, and for patients and families facing one, understanding the process in advance can make it considerably less overwhelming. This guide walks through what a transplant involves, from the initial decision through to recovery, in the order a patient typically experiences it.

Bone marrow is where blood cells are produced. In certain blood cancers and bone marrow failure conditions, the marrow either stops functioning properly or needs to be replaced after high-dose treatment aimed at eliminating disease. A bone marrow transplant, also called a hematopoietic stem cell transplant, introduces healthy blood-forming stem cells to rebuild the marrow's ability to make normal red cells, white cells, and platelets.

There are two main types. In an autologous transplant, a patient's own stem cells are collected and stored in advance, then given back after high-dose therapy; because the cells are the patient's own, there is no risk of rejection. In an allogeneic transplant, stem cells come from a donor, typically a matched sibling, a matched unrelated donor identified through a donor registry, or in some cases a haploidentical, or half-matched, family member. The choice between them depends on the specific diagnosis, donor availability, and the patient's overall health, and is decided by the treating haematologist.

Before transplant, patients undergo a thorough evaluation including blood tests, organ function tests (particularly heart, lung, kidney, and liver function), imaging, and confirmation of disease status. For allogeneic transplants, this stage also includes human leukocyte antigen (HLA) typing to find a suitable donor match. This workup confirms the patient is fit for the procedure and helps the team plan the right transplant type and conditioning approach.

Conditioning therapy, usually chemotherapy sometimes combined with other treatment, is given over several days before the transplant to reduce disease burden and prepare the body to accept the incoming stem cells. On transplant day, referred to as Day 0, healthy stem cells are infused into the bloodstream through a central line, a process that resembles a blood transfusion rather than surgery.

Over the following two to four weeks, patients are closely monitored, usually as inpatients, while the new stem cells travel to the bone marrow and begin producing new blood cells, a process called engraftment. This period carries the highest risk of infection and bleeding, since blood counts are very low until engraftment is established, so supportive care, including medications and sometimes transfusions, is an important part of this phase.

After discharge, regular follow-up visits track blood counts, immune system recovery, and, for allogeneic transplants, monitoring for graft-versus-host disease, a condition in which donor immune cells react against the recipient's tissues. Visit frequency is gradually reduced as recovery progresses over the following months. Full immune recovery can take many months to a year or more, during which patients are usually advised to take precautions around infection risk, food safety, and sun exposure, with specific guidance from the transplant team.

Because transplant involves a lengthy inpatient stay and an extended recovery period, logistical planning matters as much as medical preparation. This includes arranging caregiver support during the hospital stay, planning for time away from work, understanding the financial aspects of treatment in advance, and preparing the home environment for the post-discharge recovery period, when infection precautions are especially important. Many centres provide pre-transplant counseling to walk patients and families through what to expect at each stage.